[SYRE] QoQ Quarter Result on 31-Mar-2018 [#Q1]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
31-Mar-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- -25.24%
YoY- -29.97%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue 0 0 2,378 1,510 1,482 1,261 1,479 -
PBT -14,898 -11,917 -9,414 -8,119 -6,483 -7,874 -6,632 71.27%
Tax 0 0 0 0 0 0 0 -
NP -14,898 -11,917 -9,414 -8,119 -6,483 -7,874 -6,632 71.27%
Tax Rate - - - - - - - -
Total Cost 14,898 11,917 11,792 9,629 7,965 9,135 8,111 49.81%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin 0.00 0.00 -395.88 -537.68 -437.45 -624.43 -448.41 -
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
EPS 0.00 -13.55 -11.43 -12.17 0.00 -12.00 -11.75 -
EPS Diluted 0.00 -13.55 -11.43 -12.17 0.00 -12.00 -11.75 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.